Delivery Order SPE2DB24D2010-SPE2DB24FZUN3

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $14,230.94 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG tablets. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,975.44 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG TABLET medication. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,008.51 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XELJANZ XR 11 MG TABLET in quantities of 30S. The $4,159.92 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $19,660.26 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG TABLET to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $84,703.51 Delivery Order is for the provision of XELJANZ XR 11 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of July 16, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $4,917.36, is a Delivery Order for the supply of XELJANZ XR 11 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a completion date of June 18, 2024. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,055 delivery order is for the supply of XELJANZ XR 11 MG TABLET medication. The contract has a firm fixed price and an ultimate completion date of October 9, 2024. Amerisourcebergen is a major pharmaceutical and medical supply distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,954.43 firm fixed-price Delivery Order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The $13,354.95 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG TABLET prescription medication. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZUN3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,919.25 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG Tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. This order does not have a set-aside designation. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.

Generated 8/25/24, 12:15 AM